Work

Supplementary Table 2 from Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 2 from Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer

DOI: 10.1158/0008-5472.22386092

Authors: Igor Shats, Michael L. Gatza, Jeffrey T. Chang, Seiichi Mori, Jialiang Wang, Jeremy Rich, Joseph R. Nevins

Language: English

Topic: Cancer Cells and Metastasis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362238416

Cites:

Cited by:

Related to: 10